MiNK Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class invariant natural killer T (iNKT) cell therapies to transform the lives of patients with cancer.
Data provided by Kaleidoscope.
Events and Presentations
September 13, 2023 at 2:30 PM EDT
September 12, 2023 at 12:15 PM EDT
June 13, 2023 at 10:30 AM EDT